Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 2
2006 2
2007 1
2008 1
2009 2
2015 1
2016 1
2018 1
2019 2
2020 2
2021 4
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.
Jono T, Kasai Y, Kessoku T, Ogata T, Tanaka K, Yoshihara T, Misawa N, Kato S, Higurashi T, Hosono K, Yoneda M, Seita K, Kato T, Sakai E, Kurihashi T, Nakatogawa M, Oyamada S, Futagami S, Gwee KA, Nakajima A. Jono T, et al. Among authors: kasai y. J Neurogastroenterol Motil. 2024 Jan 30;30(1):87-96. doi: 10.5056/jnm22162. Epub 2023 Nov 28. J Neurogastroenterol Motil. 2024. PMID: 38012092 Free PMC article.
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: kasai y. Hepatol Commun. 2023 Oct 31;7(11):e0285. doi: 10.1097/HC9.0000000000000285. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37902528 Free PMC article.
Difference in target dose distributions between Acuros XB and collapsed cone convolution/superposition and the impact of the tumor locations in clinical cases of stereotactic ablative body radiotherapy for lung cancer.
Inoue K, Matsukawa H, Kasai Y, Edamitsu K, Matsumoto K, Suetsugu Y, Hirose TA, Fukunaga JI, Shioyama Y, Sasaki T. Inoue K, et al. Among authors: kasai y. J Cancer Res Ther. 2023 Jul-Sep;19(5):1261-1266. doi: 10.4103/jcrt.jcrt_1740_21. J Cancer Res Ther. 2023. PMID: 37787293 Free article.
Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care.
Tanaka K, Ohkubo H, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Kobayashi T, Yoshihara T, Misawa N, Fuyuki A, Kato S, Higurashi T, Hosono K, Yoneda M, Kurihashi T, Taguri M, Nakajima A, Gwee KA, Kessoku T. Tanaka K, et al. Among authors: kasai y. J Neurogastroenterol Motil. 2023 Jul 30;29(3):378-387. doi: 10.5056/jnm22152. J Neurogastroenterol Motil. 2023. PMID: 37417265 Free PMC article.
Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
Futagami S, Kessoku T, Kasai Y, Higurashi T, Nakajima A, Agawa S, Yamawaki H, Nakamura K, Habiro M, Kawawa R, Ueki N, Higashida S, Watanabe Y, Yamato H, Yamamoto T, Takasaki Y, Ito K, Hojo M, Isayama H, Motoda N, Ohashi R, Siah KTH, Ng CK, Gwee KA. Futagami S, et al. Among authors: kasai y. J Gastroenterol Hepatol. 2023 Oct;38(10):1778-1786. doi: 10.1111/jgh.16250. Epub 2023 Jun 6. J Gastroenterol Hepatol. 2023. PMID: 37278449
Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver disease.
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Yamamoto A, Takahashi K, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Oyamada S, Kobayashi N, Aishima S, Saito S, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: kasai y. JGH Open. 2022 Aug 24;6(10):696-703. doi: 10.1002/jgh3.12808. eCollection 2022 Oct. JGH Open. 2022. PMID: 36262543 Free PMC article.
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study.
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Yamamoto A, Takahashi K, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Yoneda M, Kobayashi N, Saito S, Nakajima A. Iwaki M, et al. Among authors: kasai y. BMJ Open. 2022 Jul 12;12(7):e060335. doi: 10.1136/bmjopen-2021-060335. BMJ Open. 2022. PMID: 35820743 Free PMC article.
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation.
Yamamoto A, Kessoku T, Tanaka K, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Kobayashi T, Yoshihara T, Misawa N, Ohkuma K, Fuyuki A, Higurashi T, Hosono K, Yoneda M, Iwasaki T, Kurihashi T, Nakatogawa M, Suzuki A, Taguri M, Oyamada S, Ariyoshi K, Kobayashi N, Ichikawa Y, Nakajima A. Yamamoto A, et al. Among authors: kasai y. Contemp Clin Trials Commun. 2022 Jun 27;28:100958. doi: 10.1016/j.conctc.2022.100958. eCollection 2022 Aug. Contemp Clin Trials Commun. 2022. PMID: 35812817 Free PMC article.
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.
Tanaka K, Kessoku T, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Kobayashi T, Yoshihara T, Misawa N, Kato T, Arimoto J, Fuyuki A, Sakai E, Higurashi T, Chiba H, Hosono K, Yoneda M, Iwasaki T, Kurihashi T, Nakatogawa M, Suzuki A, Taguri M, Oyamada S, Ariyoshi K, Kobayashi N, Ichikawa Y, Nakajima A. Tanaka K, et al. Among authors: kasai y. BMJ Open. 2022 May 30;12(5):e060704. doi: 10.1136/bmjopen-2021-060704. BMJ Open. 2022. PMID: 35636802 Free PMC article. Clinical Trial.
36 results